Medimmune Ventures, Inc.'s Net Worth
Medimmune Ventures, Inc.'s net worth is estimated to be at least $13,277,911.50 as of 12/23/2024. CoreStreet's estimation of Medimmune Ventures, Inc.'s net worth is based on their sale of stock and current holding of stock.
Medimmune Ventures, Inc. is Major Shareholder at G1 Therapeutics Inc. They have executed at least 4 trades of stock as per SEC Form 4 filings. Their most recent trade was for 200,000 units of GTHX stock on 12/15/2017. Their biggest sale was on 11/20/2017 when they sold 200,000 units of G1 Therapeutics Inc stock for $4,002,000.00. They typically trade 2 times per year.
Total value of insider buys:
- $2,681,268.00
Total value of insider sells:
- $10,596,643.50
Most recent insider trade:
- Dec. 15, 2017
Medimmune Ventures, Inc.'s Insider Trading History
| G1 Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Dec. 15, 2017 | Major Shareholder | 200,000 | $19.75 | Sell | $3,950,000.00 |
Dec. 1, 2017 | Major Shareholder | 133,906 | $19.75 | Sell | $2,644,643.50 |
Nov. 20, 2017 | Major Shareholder | 200,000 | $20.01 | Sell | $4,002,000.00 |
| Astria Therapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
June 30, 2015 | Major Shareholder | 223,439 | $12.00 | Buy | $2,681,268.00 |